This HTML5 document contains 186 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n6	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0139066/price-of-originator/
n3	http://linked.opendata.cz/ontology/sukl/
n13	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0139066/reimbursement/
n14	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0139066/
n17	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0139066/core-reimbursement/
skos	http://www.w3.org/2004/02/skos/core#
n18	http://linked.opendata.cz/resource/sukl/indgroup/
n11	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0139066/price/
n19	http://linked.opendata.cz/resource/sukl/packing/
n10	http://linked.opendata.cz/resource/sukl/company/
n9	http://linked.opendata.cz/resource/sukl/active-ingredient/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n7	http://www.sukl.cz/modules/medication/
n20	http://linked.opendata.cz/resource/sukl/df/
n5	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0139066

rdf:type

n3:MedicinalProductPackaging

dcterms:title

DOXORUBICIN TEVA 2 MG/ML

skos:notation

0139066

n3:hasATCCode

n5:L01DB01

n3:hasActiveIngredient

n9:DOXORUBICINI-HYDROCHLORIDUM

n3:hasDefinedDailyDose

n15:ddd

n3:hasDosageForm

n20:CNC-SOL-INF

n3:hasPackagingSize

100ML

n3:hasPacking

n19:VIA

n3:hasRegistrationHolder

n10:TPPCZ

n3:hasRegistrationState

n12:R

n3:hasRouteOfAdministration

n6:INF

n3:hasStrength

2MG/ML

n3:hasIndicationGroup

n18:44

n3:hasSpecializationRestriction

n14:ONK n14:HEM

n3:containsDefinedDailyDoses

0.0

n3:hasRegistrationCode

44/ 850/09-C

n3:hasTitleSupplement

INF CNC SOL 1X100ML/200MG

n3:containsUsualTherapeuticalDailyDoses

40.4858

n3:hasBreakMarketingDate

2012-09-17+02:00

n3:hasCoreReimbursementSpecification

n17:2015-07-01 n17:2015-07-02 n17:2015-05-01 n17:2015-06-01 n17:2015-04-01 n17:2015-04-02 n17:2015-02-01 n17:2015-03-01 n17:2015-01-01 n17:2015-01-13 n17:2014-11-19 n17:2014-12-01 n17:2014-10-02 n17:2014-11-01 n17:2014-09-01 n17:2014-10-01 n17:2014-07-03 n17:2014-08-01 n17:2014-06-13 n17:2014-07-01 n17:2014-05-01 n17:2014-06-01 n17:2014-03-01 n17:2014-04-01 n17:2014-01-01 n17:2014-02-01 n17:2013-11-01 n17:2013-12-01 n17:2013-09-01 n17:2013-10-01 n17:2013-08-01 n17:2013-08-03 n17:2013-06-01 n17:2013-07-01 n17:2013-04-01 n17:2013-05-01 n17:2013-02-01 n17:2013-03-01 n17:2013-01-01 n17:2013-01-05

n3:hasPriceOfOriginatorSpecification

n4:2013-01-01 n4:2013-01-05 n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-07-01 n4:2015-07-02

n3:hasPriceSpecification

n11:2013-01-01 n11:2013-01-05 n11:2013-06-01 n11:2013-07-01 n11:2013-08-01 n11:2013-08-03 n11:2013-02-01 n11:2013-03-01 n11:2013-04-01 n11:2013-05-01 n11:2014-01-01 n11:2014-02-01 n11:2014-03-01 n11:2014-04-01 n11:2013-09-01 n11:2013-10-01 n11:2013-11-01 n11:2013-12-01 n11:2014-07-03 n11:2014-08-01 n11:2014-09-01 n11:2014-10-01 n11:2014-05-01 n11:2014-06-01 n11:2014-06-13 n11:2014-07-01 n11:2015-01-01 n11:2015-01-13 n11:2015-02-01 n11:2015-03-01 n11:2014-10-02 n11:2014-11-01 n11:2014-11-19 n11:2014-12-01 n11:2015-07-01 n11:2015-07-02 n11:2015-04-01 n11:2015-04-02 n11:2015-05-01 n11:2015-06-01

n3:hasReimbursementSpecification

n13:2013-01-01 n13:2013-01-05 n13:2013-08-01 n13:2013-08-03 n13:2013-06-01 n13:2013-07-01 n13:2013-04-01 n13:2013-05-01 n13:2013-02-01 n13:2013-03-01 n13:2014-03-01 n13:2014-04-01 n13:2014-01-01 n13:2014-02-01 n13:2013-11-01 n13:2013-12-01 n13:2013-09-01 n13:2013-10-01 n13:2014-09-01 n13:2014-10-01 n13:2014-07-03 n13:2014-08-01 n13:2014-06-13 n13:2014-07-01 n13:2014-05-01 n13:2014-06-01 n13:2015-02-01 n13:2015-03-01 n13:2015-01-01 n13:2015-01-13 n13:2014-11-19 n13:2014-12-01 n13:2014-10-02 n13:2014-11-01 n13:2015-07-01 n13:2015-07-02 n13:2015-05-01 n13:2015-06-01 n13:2015-04-01 n13:2015-04-02

n3:hasResumedMarketingDate

2013-02-22+01:00 2012-07-23+02:00

n3:hasUsualTherapeuticalDailyDose

n15:utdd

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC62477.pdf%26type%3Dspc%26as%3Ddoxorubicin-teva-2-mg-ml-spc

n3:spcUri

n7:download.php?file=SPC62477.pdf&type=spc&as=doxorubicin-teva-2-mg-ml-spc